Patent problemsIt’s not just developing or poor countries that are struggling with high drug prices. The US Senate Finance Committee launched a bipartisan probe to examine drug pricing in the United States and the rising costs for consumers and taxpayers. It is morally repugnant when patients are forced to skip doses.”Top executives from the seven largest drug companies were also hauled up before the committee to explain the skyrocketing cost of prescription drugs. On Wednesday, the committee tweeted again, saying: “@HHSGov is starting to look into drug company middlemen that take millions from taxpayers. The industry is also pushing back against Euripid’s ambitions to shift its focus from list prices to net prices, PharmExec.com reports.

Source: The Star May 19, 2019 01:07 UTC